Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Stock
Equities
002223
CNE1000009X3
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 36.14 CNY | -0.14% |
|
+1.23% | -0.96% |
| Capitalization | 36.08B 5.1B 4.39B 4.11B 3.83B 7.07B 459B 7.69B 48.06B 18.56B 217B 19.15B 18.74B 793B | P/E ratio 2025 * |
18.7x | P/E ratio 2026 * | 16x |
|---|---|---|---|---|---|
| Enterprise value | 28.85B 4.08B 3.51B 3.29B 3.06B 5.66B 367B 6.15B 38.44B 14.84B 173B 15.32B 14.99B 634B | EV / Sales 2025 * |
3.39x | EV / Sales 2026 * | 2.94x |
| Free-Float |
57.42% | Yield 2025 * |
1.73% | Yield 2026 * | 1.99% |
| 1 day | -0.14% | ||
| 1 week | +1.23% | ||
| Current month | +1.23% | ||
| 1 month | +3.20% | ||
| 3 months | -2.32% | ||
| 6 months | -2.48% | ||
| Current year | -0.96% |
| 1 week | 35.35 |  | 36.31 |
| 1 month | 35 | | 36.85 |
| Current year | 32.43 | | 41.93 |
| 1 year | 32.43 | | 41.93 |
| 3 years | 29.31 | | 42.08 |
| 5 years | 20.84 | | 42.18 |
| 10 years | 15.53 | | 42.18 |
| Manager | Title | Age | Since |
|---|---|---|---|
Qun Wu
CEO | Chief Executive Officer | 37 | 2019-04-17 |
Yong Zhang
DFI | Director of Finance/CFO | 52 | 2021-05-09 |
Rui Jie Wang
SEC | Corporate Secretary | 33 | 2020-10-26 |
| Director | Title | Age | Since |
|---|---|---|---|
Qun Wu
CHM | Chairman | 37 | 2020-10-26 |
Ming Xia Zhong
BRD | Director/Board Member | 61 | 2022-12-07 |
Ying Fang Lü
CHM | Chairman | 58 | 2020-10-26 |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
 | 0.54% | 0 M€ | -19.71% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.14% | +1.23% | +7.24% | +0.61% | 5.1B | |
| -0.01% | +0.01% | +0.01% | +37.71% | 12.57B | |
| +2.02% | +2.55% | +23.88% | +41.82% | 11.77B | |
| -0.41% | -0.53% | -16.36% | -0.61% | 7.61B | |
| +0.24% | -1.72% | +24.93% | -16.39% | 6.11B | |
| -0.03% | +4.60% | +14.22% | +22.64% | 5.23B | |
| -0.17% | +3.12% | -7.29% | +75.93% | 4.82B | |
| +0.05% | -.--% | +55.10% | +12.46% | 4.7B | |
| -1.00% | -5.18% | +52.99% | -16.68% | 2.01B | |
| +1.23% | -0.82% | +3.18% | -49.72% | 1.62B | |
| Average | +0.18% | -0.17% | +15.79% | +10.78% | 6.15B | |
| Weighted average by Cap. | +0.33% | +0.42% | +12.28% | +21.01% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 8.5B 1.2B 1.03B 969M 903M 1.67B 108B 1.81B 11.33B 4.37B 51.13B 4.51B 4.42B 187B | 9.64B 1.36B 1.17B 1.1B 1.02B 1.89B 123B 2.06B 12.84B 4.96B 57.95B 5.12B 5.01B 212B |
| Net income | 1.93B 274M 235M 220M 205M 379M 24.62B 413M 2.58B 995M 11.63B 1.03B 1B 42.52B | 2.27B 321M 276M 258M 241M 445M 28.86B 483M 3.02B 1.17B 13.63B 1.2B 1.18B 49.83B |
| Net Debt | -7.22B -1.02B -878M -822M -767M -1.42B -91.92B -1.54B -9.62B -3.71B -43.41B -3.83B -3.75B -159B | -7.72B -1.09B -939M -880M -820M -1.51B -98.33B -1.65B -10.29B -3.97B -46.44B -4.1B -4.01B -170B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-12-05 | 36.14 ¥ | -0.14% | 4,639,490 |
| 25-12-04 | 36.19 ¥ | +0.44% | 3,358,153 |
| 25-12-03 | 36.03 ¥ | +0.59% | 4,544,603 |
| 25-12-02 | 35.82 ¥ | -1.19% | 4,175,980 |
| 25-12-01 | 36.25 ¥ | +1.54% | 6,904,200 |
End-of-day quote Shenzhen S.E., December 04, 2025
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 002223 Stock
Select your edition
All financial news and data tailored to specific country editions
